Merck announced the launch of Evidence for Impact 2022, the third research compendium supported by Merck for Mothers. The compendium was created to highlight the work of our diverse collaborators from leading academic centers, advocacy groups, non-governmental organizations and others. The compendium was created to highlight the work of our diverse collaborators from leading academic centers, advocacy groups, non-governmental organizations and others.
Around the world, visionary leaders and community-based organizations are creating a path to a better world where maternal health outcomes are more equitable, and pregnancy and childbirth are safer. They are helping to create a world where prenatal visits, labor and delivery and postpartum encounters for the first year after childbirth contribute to healthier maternal health outcomes.
By bringing together more than 170 publications, including 40+ peer-reviewed journal articles, published since mid-2020, Evidence for Impact 2022 aggregates leading-edge research and the application of new research methodologies that shed light on critical questions and longstanding challenges in maternal health. Included are insights ranging from the potential of digital solutions to elicit feedback from women about their care to the power of capacity-building to help local health providers deliver quality maternal health and family planning services closer to the people they serve.
Building on learnings from earlier editions, Merck for Mothers has broadened this report’s focus to include a variety of sources, not limited to peer-reviewed publications, as a way to share findings in shorter time frames so that policymakers, public health practitioners and health providers can more easily use these insights to inform ongoing efforts to help save lives. Additionally, keeping with Merck for Mothers’ commitment to action based on evidence, Evidence for Impact 2022 includes practical tools that our collaborators have developed to put research findings into practice.
“This research was examined through a lens to health equity to demonstrate that we can close health equity gaps by focusing efforts on communities that are most affected,” said Dr. Mary-Ann Etiebet, AVP, health equity and lead, Merck for Mothers. “Through Evidence for Impact 2022, Merck for Mothers hopes that the research findings and tools that our collaborators have produced will inspire continued innovation in global health, accelerate the deployment of evidenced-based solutions and contribute to saving many more women’s lives.”
To read the full report, visit here .